Ozempic is a GLP-1 receptor agonist that improves blood glucose control and often leads to weight reduction
The STEP 1 trial, which is the largest clinical study on semaglutide 2.4 mg for weight management, followed nearly 2,000 adults over 68 weeks and documented these outcomes in detail
Am J Alzheimers Dis Other Demen
Managing Side Effects Most side effects of Semaglutide can be managed with supportive care and adjustments to the treatment regimen
Read More :- High Protein Diet for Weight Loss: A Complete Beginners Guide Clinical results: The STEP clinical trial program, which enrolled over 4,500 adults with obesity, showed that participants taking semaglutide 2.4 mg lost an average of 14.9 percent of their body weight over 68 weeks
Ozempic is sensitive to temperatures, as it must be stored at certain conditions in order to maintain its effectiveness